CDMO Contract Signed with Largest Shareholder Invetix Lab
-
Signed CDMO contract with largest shareholder Invetix Lab
-
Term: 2026.04.08~2029.04.07 (3 years), conditional contract, amount undisclosed
-
Advance payment exists, payment by production milestones
-
Company's latest sales: 2,456M KRW, counterparty's sales: 2,938M KRW (2025 consolidated)
KOSDAQ Filing Information
-
Filing: Conclusion of a Single Sales and Supply Contract
-
Company: Quratis (348080)
-
Submission: Quratis Inc.
-
Receipt: 04-08-2026
-
Under KRX KOSDAQ Market Division